Psychedelics Optimi Health launches ibogaine initiative in response to Trump’s executive order Psychedelic stocks surged after the president gave his signature Rowan DunneApril 21, 2026
Psychedelics Trump prepares to sign executive order for expedited ibogaine research Sources just informed CBS News about the significant development Rowan DunneApril 17, 2026
Cannabis Bioxyne to manufacture Aurora Cannabis products for international distribution The company went from a one-person operation to partnering with one of the world's cannabis majors Rowan DunneApril 6, 2026
Psychedelics Israeli scientists get tobacco to produce an array of psychedelic compounds The novel method has significant implications for clinical psychedelic drug production Rowan DunneApril 2, 2026
Psychedelics Deutsche Bank initiates bullish coverage of psychedelics company AtaiBeckley The financial institution has given the drug developer a Buy rating a US$12 share target Rowan DunneMarch 31, 2026
Psychedelics Psilocybin truffle maker Red Light Holland to acquire financially distressed Filament Health Both companies have balance sheets with concerning numbers Rowan DunneMarch 11, 2026
Psychedelics Psychedelic retreat organiser charged with manslaughter over 2021 incident He provided a guest with ayahuasca and administered frog venom (kambo) in Australia Rowan DunneMarch 5, 2026
Psychedelics Non-profit Heroic Hearts publishes psychedelics guide for veterans 'Psychedelics: The Veteran's Field Manual' provides guidance about controversial and increasingly popular therapies Rowan DunneFebruary 19, 2026
Psychedelics American DEA boosts psychedelic drug production quotas The agency increases production every year as domestic research demands escalate Rowan DunneJanuary 6, 2026
Bitcoin The year 2025 in review: A Mugglehead roundup Innovation created new avenues for wealth creation, but also exposed structural weaknesses and human error Joseph MortonDecember 30, 2025